MCID: CHL054
MIFTS: 10

Childhood Pleomorphic Rhabdomyosarcoma

Categories: Cancer diseases, Muscle diseases

Aliases & Classifications for Childhood Pleomorphic Rhabdomyosarcoma

MalaCards integrated aliases for Childhood Pleomorphic Rhabdomyosarcoma:

Name: Childhood Pleomorphic Rhabdomyosarcoma 12
Pleomorphic Childhood Rhabdomyosarcoma 70
Childhood Anaplastic Rhabdomyosarcoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:7463
NCIt 50 C7959
UMLS 70 C0279614

Summaries for Childhood Pleomorphic Rhabdomyosarcoma

MalaCards based summary : Childhood Pleomorphic Rhabdomyosarcoma, is also known as pleomorphic childhood rhabdomyosarcoma. The drugs Etoposide and Vincristine have been mentioned in the context of this disorder. Affiliated tissues include bone.

Related Diseases for Childhood Pleomorphic Rhabdomyosarcoma

Symptoms & Phenotypes for Childhood Pleomorphic Rhabdomyosarcoma

Drugs & Therapeutics for Childhood Pleomorphic Rhabdomyosarcoma

Drugs for Childhood Pleomorphic Rhabdomyosarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 33)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Etoposide Approved Phase 3 33419-42-0 36462
2
Vincristine Approved, Investigational Phase 3 2068-78-2, 57-22-7 5978
3
Epirubicin Approved Phase 3 56420-45-2 41867
4
Dactinomycin Approved, Investigational Phase 3 50-76-0 2019 457193
5
Ifosfamide Approved Phase 3 3778-73-2 3690
6
Carboplatin Approved Phase 3 41575-94-4 10339178 498142 38904
7
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
8
Histamine Approved, Investigational Phase 3 51-45-6, 75614-87-8 774
9
Cyproheptadine Approved Phase 3 129-03-3 2913
10 Tubulin Modulators Phase 3
11 Antibiotics, Antitubercular Phase 3
12 Immunosuppressive Agents Phase 3
13 Alkylating Agents Phase 3
14 Anti-Infective Agents Phase 3
15 Antirheumatic Agents Phase 3
16 Immunologic Factors Phase 3
17 Etoposide phosphate Phase 3
18 Anti-Bacterial Agents Phase 3
19
Isophosphamide mustard Phase 3 100427
20 Antimitotic Agents Phase 3
21 Gastrointestinal Agents Phase 3
22 Neurotransmitter Agents Phase 3
23 Dermatologic Agents Phase 3
24
Histamine Phosphate Phase 3 51-74-1 65513
25 Histamine H1 Antagonists Phase 3
26 Histamine Antagonists Phase 3
27 Anti-Allergic Agents Phase 3
28
Serotonin Investigational, Nutraceutical Phase 3 50-67-9 5202
29
Lenograstim Approved, Investigational Phase 2 135968-09-1
30
Doxorubicin Approved, Investigational Phase 2 23214-92-8 31703
31 Imatinib Mesylate Phase 2 220127-57-1 123596
32 Protein Kinase Inhibitors Phase 2
33
Liposomal doxorubicin Phase 2 31703

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 MMT 95 Study For Rhabdomyosarcoma and Other Malignant Soft Tissue Tumors of Childhood Completed NCT00002898 Phase 3 carboplatin;cyclophosphamide;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
2 Prevention of Cancer/Treatment-Related Weight Loss in Children at High Nutritional Risk Terminated NCT01132547 Phase 3 cyproheptadine hydrochloride
3 Phase II Trial of Gleevec (Formerly Known as STI571) in Patients With Soft Tissue and Bone Sarcomas: A Multi-Disciplinary Trial of the North American Sarcoma Study Group of the Connective Tissue Oncology Society Completed NCT00031915 Phase 2 imatinib mesylate
4 MMT 98 Study For Metastatic Disease Rhabdomyosarcoma And Other Malignant Soft Tissue Sarcoma Of Childhood Completed NCT00025441 Phase 2 carboplatin;cyclophosphamide;doxorubicin hydrochloride;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
5 DNA Methylation-based Assays for Detecting Disease Spread in Rhabdomyosarcoma Completed NCT01419509

Search NIH Clinical Center for Childhood Pleomorphic Rhabdomyosarcoma

Genetic Tests for Childhood Pleomorphic Rhabdomyosarcoma

Anatomical Context for Childhood Pleomorphic Rhabdomyosarcoma

MalaCards organs/tissues related to Childhood Pleomorphic Rhabdomyosarcoma:

40
Bone

Publications for Childhood Pleomorphic Rhabdomyosarcoma

Variations for Childhood Pleomorphic Rhabdomyosarcoma

Expression for Childhood Pleomorphic Rhabdomyosarcoma

Search GEO for disease gene expression data for Childhood Pleomorphic Rhabdomyosarcoma.

Pathways for Childhood Pleomorphic Rhabdomyosarcoma

GO Terms for Childhood Pleomorphic Rhabdomyosarcoma

Sources for Childhood Pleomorphic Rhabdomyosarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Apr-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....